GQG Partners LLC acquired a new position in Merck KGaA (OTCMKTS:MKGAF – Free Report) during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission. The fund acquired 53,092 shares of the company’s stock, valued at approximately $6,822,000.
Other large investors have also recently made changes to their positions in the company. Danske Bank A S acquired a new stake in shares of Merck KGaA during the second quarter worth about $276,535,000. Korea Investment CORP purchased a new stake in Merck KGaA during the second quarter worth approximately $239,191,000. Great Lakes Advisors LLC acquired a new position in shares of Merck KGaA in the 2nd quarter valued at $183,444,000. Ieq Capital LLC purchased a new position in shares of Merck KGaA during the second quarter worth about $102,699,000. Finally, Tocqueville Asset Management L.P. acquired a new stake in shares of Merck KGaA during the second quarter worth about $57,546,000. 0.10% of the stock is currently owned by institutional investors and hedge funds.
Merck KGaA Stock Up 0.7%
Shares of OTCMKTS MKGAF opened at $163.21 on Friday. The business has a 50-day moving average price of $162.62 and a 200 day moving average price of $148.46. The stock has a market cap of $21.09 billion, a PE ratio of 24.92 and a beta of 0.96. The company has a quick ratio of 0.84, a current ratio of 1.31 and a debt-to-equity ratio of 0.27. Merck KGaA has a 52-week low of $116.68 and a 52-week high of $175.56.
Merck KGaA Company Profile
Merck KGaA, headquartered in Darmstadt, Germany, is a long-established multinational chemical and pharmaceutical company with roots dating back to 1668. Operating under the brand Merck Group (and using distinct consumer-facing names in certain regions to avoid confusion with other companies of similar name), the company is privately controlled by the Merck family and organizes its activities across multiple business units that serve customers in Europe, the Americas, Asia-Pacific and beyond.
The company’s operations are organized mainly into three businesses.
Featured Stories
- Five stocks we like better than Merck KGaA
- 2 Biotech Stocks Shaping Up for Major Breakouts
- 3 Stocks Came Roaring Back—Now They’re Flashing Warning Signs
- 3 Beaten-Down Stocks That Haven’t Gotten the Message About the S&P 500’s Record Run
- Darden Restaurants Just Hit a 52-Week High–Is the Olive Garden Comeback Story Legit?
Want to see what other hedge funds are holding MKGAF? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Merck KGaA (OTCMKTS:MKGAF – Free Report).
Receive News & Ratings for Merck KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merck KGaA and related companies with MarketBeat.com's FREE daily email newsletter.
